Drug trials firm to challenge plans for greater transparency over results
by Sarah Boseley Health editor from on (#98T1)
A judicial review will examine Health Research Authority plans for firms to publish all results, even when a drug is shown not to be beneficial
The long-fought battle for greater transparency in human drug trials is facing a major setback after a legal challenge against full disclosure from within the pharmaceutical industry.
The Health Research Authority, which authorises trials and works to ensure the safety of patients taking part, has proposed that all drug trials must in future be registered. A judicial review has now been brought by a leading clinical trials company, challenging the plans for reform.
Related: Drug companies accused of holding back complete information on clinical trials
Continue reading...